{
    "medicine_id": "6152a39ecd79d6966b090e0c45af9b803d41d52e",
    "platform_id": "DB05490",
    "metadata": {
        "name": "Adult Formula 50 60 61 v v Solution",
        "composition": "60 61 v v AMG 131",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in diabetes mellitus type 2",
            "contraindications": {
                "disease": "In preclinical studies comparing T131 to Avandia T131 demonstrated superior potency and an improved side effect profile In these studies T131 treatment did not result in fluid retention or cardiac hypertrophy In Phase 1 studies with T131 all doses were well tolerated and no serious adverse events were observed",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "T131 an orally administered therapy is expected to lower blood glucose in type II diabetic patients by improving the body s ability to respond to insulin T131 is not structurally related to the thiazolidinedione class of PPARg agonists which includes Actos and Avandia",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}